0000899243-21-023896.txt : 20210615 0000899243-21-023896.hdr.sgml : 20210615 20210615171326 ACCESSION NUMBER: 0000899243-21-023896 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210615 DATE AS OF CHANGE: 20210615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dierks Jeffrey CENTRAL INDEX KEY: 0001821102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 211019536 MAIL ADDRESS: STREET 1: 630 W. GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-01 0 0001802665 Harmony Biosciences Holdings, Inc. HRMY 0001821102 Dierks Jeffrey 630 W. GERMANTOWN PIKE, SUITE 215 PLYMOUTH MEETING PA 19462 0 1 0 0 See Remarks Stock Option 33.44 2021-06-01 4 A 0 53900 0.00 A 2031-06-01 Common Stock 53900 53900 D The stock option shall vest with respect to half of the underlying shares on June 1, 2022 and with respect to the remaining shares, in forty-eight equal monthly installments beginning on July 1, 2022. Chief Commercial Officer /s/ Christian Ulrich, Attorney-in-fact for Jeffrey Dierks 2021-06-15